Anchal Trivedi

Anchal Trivedi

Auto-generated profile, based on publicly available information

Anchal Trivedi

Department of Biochemistry, Era's Lucknow Medical College and Hospital Era University Lucknow Uttar Pradesh India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SSSahabjada Siddiqui
Sahabjada Siddiqui
SUShivbrat Upadhyay
Shivbrat Upadhyay
Dr. Rumana AhmadDr. Rumana Ahmad
Dr. Rumana Ahmad
AGAnamika Gupta
Anamika Gupta
ASAditi Srivastava
Aditi Srivastava
MKMohsin Ali Khan
Mohsin Ali Khan
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel etiological agent of coronavirus disease 2019 (COVID-19). Nigella sativa, commonly known as black seed or black cumin, has been a historical and traditional plant since thousands of years. Based on their therapeutic efficacy, the chief components of terpenoids and flavonoids were selected from N. sativa seeds and seed oil. This study was designed to check the antiviral efficacy of N. sativa main phytoconstituents against five potential targets of SARS-CoV-2 using in silico structure-based virtual screening approach. Out of twenty five phytocomponents, ten components showed best binding affinity against two viral proteins viz. N-terminal RNA binding domain (NRBD; PDB ID: 6M3M) of nucleocapsid protein and papain-like protease (PL-PRO; PDB ID: 6W9C) of SARS-CoV-2 using AutoDock 4.2.6, AutoDock Vina and iGEMDOCK. PASS analyses of all ten phytocomponents using Lipinski’s Rule of five showed promising results. Further, druglikeness and toxicity assessment using OSIRIS Data Warrior v5.2.1 software exhibited the feasibility of phytocomponents as drug candidates with no predicted toxicity. Molecular dynamics simulation study of NRBD of SARS-CoV-2 nucleocapsid protein-alpha-spinasterol complex and PL-PRO-cycloeucalenol complex displayed strong stability at 300 K. Both these complexes exhibited constant root mean square deviation (RMSDs) of protein side chains and Cα atoms throughout the simulation run time. Interestingly, PL-PRO and NRBD are key proteins in viral replication, host cell immune evasion and viral assembly. Thus, NRBD and PL-PRO have the potential to serve as therapeutic targets for N. sativa phytoconstituents in drug discovery process against COVID-19. Graphical Abstract Communicated by Ramaswamy H. Sarma


31 December 2025 in Tissue and Cell
Verified
Journal Article
Closed access
IHIshrat Husain
Ishrat Husain
ACAnu Chandra
Anu Chandra
MSMrinal Ranjan Srivastava
Mrinal Ranjan Srivastava
FMFarzana Mahdi
Farzana Mahdi
RARumana Ahmad
Rumana Ahmad

26 October 2021 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
ESEsha Sarkar
Esha Sarkar
AMAparna Misra
Aparna Misra
AMAbbas Ali Mahdi
Abbas Ali Mahdi
ATAnchal Trivedi
Anchal Trivedi
AKAfreen Khan
Afreen Khan
Chemoresistance is one of the biggest hurdles while treating cancer clinically. Due to its heterogeneous nature, complications of the chemoresistance mechanisms of breast cancer cannot be completely elucidated. Existing mechanisms of main-line drug treatment can slow down the process of malignancy with part and parcel called drug resistance. The combinatorial effect of several chemotherapeutic drugs, targeting different pathways at the same time, can work efficiently, yet the toxicity and drug-drug interaction remain intact. To overcome this hurdle, a number of strategies have been discovered, such as novel agents, drug carriers, and combination treatment, etc., which target mediated drug delivery systems; nanomedicine and the use of phytocompounds can transfer the drug particularly to the cancerous cells with minimal side effects to the neighboring healthy cells. The cell cycle checkpoint proteins and genes induced to the deranged cells can inhibit the resistance mechanism towards the drug. Modification of cell signaling pathways can also help to treat breast cancer chemoresistance mechanisms in the long run. This article reviews the execution and onset of chemoresistance in various cancers and discusses potential therapeutic approaches to deal with the resistance mechanism. This review summarizes the possible mechanisms and signaling pathways causing chemoresistance in breast cancer cell lines and discusses alternative therapy to overcome this issue under pre-clinical and clinical infrastructure.